Metabolic Diversity in Tumors Assessed by 18F-FDG PET/CT as a Prognostic Indicator in Diffuse Large B-Cell Lymphoma - Quiz - MDSpire

Metabolic Diversity in Tumors Assessed by 18F-FDG PET/CT as a Prognostic Indicator in Diffuse Large B-Cell Lymphoma

  • By

  • Wenchong Xin

  • Fei Wang

  • Luo Lu

  • Haoyu Zang

  • Bai He

  • Weiying Gu

  • Yuetao Wang

  • November 24, 2025

  • 0 min

Share

Original Source(s)

Metabolic Diversity in Tumors Assessed by 18F-FDG PET/CT as a Prognostic Indicator in Diffuse Large B-Cell Lymphoma

  • by Wenchong Xin, Fei Wang, Luo Lu, Haoyu Zang, Bai He, Weiying Gu, Yuetao Wang

  • November 24, 2025

Related Content

Gastric-type endocervical adenocarcinoma with Peutz-Jeghers syndrome: a case report and literature review

Financial Hardship and Nonadherence to Lifestyle and Surveillance in Childhood Cancer Survivors

High-grade astrocytoma with piloid features: a case report of comprehensive management